why choose us

First received: September 26, 2023

Clinical Trial: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Brief Summary: To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe.Phase 2 will open if the Phase 1 dose is found to be safe.To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate cancer before they have surgery to remove the disease.

Read more